News Announcement

Aurobindo Pharma: Closure of Trading Window

This is to inform that as per the Companys Internal Code of Conduct to Regulate Monitor and Report
Trading by Designated Persons the Trading Window for dealing in the securities of the Company would
remain closed for all designated persons including promoters directors key managerial personnel
employees connected persons and their immediate relatives with effect from October 1 2020 till 48 hours
after the declaration of the Unaudited Financial Results of the Company for the second quarter and six
months period ending on September 30 2020.
The date of Board Meeting for declaration of the financial results of the Company for the second quarter
and six months period ending on September 30 2020 will be intimated in due course.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.